Epilan-D

Epilan-D is a pharmaceutical product containing Phenytoin Sodium, used for managing certain medical conditions. This intravenous medication is manufactured by G.L. Pharma Gmbh and is available in the EU market.

Epilan-D, containing Phenytoin Sodium, is primarily used for the management of specific neurological conditions. It is often prescribed to control seizures and is administered intravenously. Phenytoin Sodium is known for its anticonvulsant properties, making it a key component in seizure management protocols.

Common effects of Epilan-D may include dizziness, nausea, and coordination issues. Some users might experience skin reactions or changes in mood. It is important to monitor for any adverse reactions and consult a healthcare provider if severe side effects occur.

Epilan-D should be handled with care, especially when administered intravenously. It is crucial to follow proper administration guidelines to avoid complications. Patients with a history of heart conditions or liver issues should use this medication under close supervision.

Epilan-D may interact with other medications, including those metabolized by the liver. Alcohol and certain antacids can also affect its efficacy. It is advisable to discuss all current medications with a healthcare provider before starting Epilan-D.